Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF.

Nicoletti F, Mazzon E, Fagone P, Mangano K, Mammana S, Cavalli E, Basile MS, Bramanti P, Scalabrino G, Lange A, Curtin F.

J Neuroimmunol. 2019 May 8;332:224-232. doi: 10.1016/j.jneuroim.2019.05.006. [Epub ahead of print]

PMID:
31100693
2.

Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials.

Silvestro S, Mammana S, Cavalli E, Bramanti P, Mazzon E.

Molecules. 2019 Apr 12;24(8). pii: E1459. doi: 10.3390/molecules24081459. Review.

3.

Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma.

Paskaš S, Krajnović T, Basile MS, Dunđerović D, Cavalli E, Mangano K, Mammana S, Al-Abed Y, Nicoletti F, Mijatović S, Maksimović-Ivanić D.

Mol Carcinog. 2019 Apr 17. doi: 10.1002/mc.23020. [Epub ahead of print]

PMID:
30997718
4.

Human Gingival Mesenchymal Stem Cells (GMSCs) pre-treated with vesicular Moringin nanostructures as a new therapeutic approach in a mouse model of Spinal Cord Injury.

Mammana S, Gugliandolo A, Cavalli E, Diomede F, Iori R, Zappacosta R, Bramanti P, Conti P, Fontana A, Pizzicannella J, Mazzon E.

J Tissue Eng Regen Med. 2019 Apr 3. doi: 10.1002/term.2857. [Epub ahead of print]

PMID:
30942960
5.

The neuropathic pain: An overview of the current treatment and future therapeutic approaches.

Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E.

Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419838383. doi: 10.1177/2058738419838383.

6.

KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms.

Basile MS, Fagone P, Mangano K, Mammana S, Magro G, Salvatorelli L, Li Destri G, La Greca G, Nicoletti F, Puleo S, Pesce A.

Cancers (Basel). 2019 Feb 19;11(2). pii: E245. doi: 10.3390/cancers11020245.

7.

Differential modulation and prognostic values of immune-escape genes in uveal melanoma.

Basile MS, Mazzon E, Russo A, Mammana S, Longo A, Bonfiglio V, Fallico M, Caltabiano R, Fagone P, Nicoletti F, Avitabile T, Reibaldi M.

PLoS One. 2019 Jan 17;14(1):e0210276. doi: 10.1371/journal.pone.0210276. eCollection 2019.

8.

Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis.

Fagone P, Mazzon E, Chikovani T, Saraceno A, Mammana S, Colletti G, Mangano K, Bramanti P, Nicoletti F.

J Neuroimmunol. 2018 Aug 15;321:41-48. doi: 10.1016/j.jneuroim.2018.05.013. Epub 2018 May 28.

9.

Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach.

Mangano K, Mazzon E, Basile MS, Di Marco R, Bramanti P, Mammana S, Petralia MC, Fagone P, Nicoletti F.

Oncotarget. 2018 Apr 3;9(25):17951-17970. doi: 10.18632/oncotarget.24885. eCollection 2018 Apr 3. Review.

10.

The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets.

Mammana S, Fagone P, Cavalli E, Basile MS, Petralia MC, Nicoletti F, Bramanti P, Mazzon E.

Int J Mol Sci. 2018 Mar 13;19(3). pii: E831. doi: 10.3390/ijms19030831. Review.

11.

Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis.

Mammana S, Bramanti P, Mazzon E, Cavalli E, Basile MS, Fagone P, Petralia MC, McCubrey JA, Nicoletti F, Mangano K.

Oncotarget. 2018 Jan 3;9(9):8263-8277. doi: 10.18632/oncotarget.23862. eCollection 2018 Feb 2.

12.

Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-releasing molecule CORM-A1, in a murine model of autoimmune hepatitis.

Mangano K, Cavalli E, Mammana S, Basile MS, Caltabiano R, Pesce A, Puleo S, Atanasov AG, Magro G, Nicoletti F, Fagone P.

J Cell Physiol. 2018 May;233(5):4156-4165. doi: 10.1002/jcp.26223. Epub 2017 Dec 29.

PMID:
29034470
13.

Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone.

Mangano K, Vergalito F, Mammana S, Mariano A, De Pasquale R, Meloscia A, Bartollino S, Guerra G, Nicoletti F, Di Marco R.

Exp Ther Med. 2017 Sep;14(3):2439-2444. doi: 10.3892/etm.2017.4810. Epub 2017 Jul 19.

14.

Expression of DNA methylation genes in secondary progressive multiple sclerosis.

Fagone P, Mangano K, Di Marco R, Touil-Boukoffa C, Chikovan T, Signorelli S, Lombardo GA, Patti F, Mammana S, Nicoletti F.

J Neuroimmunol. 2016 Jan 15;290:66-9. doi: 10.1016/j.jneuroim.2015.11.018. Epub 2015 Nov 24.

PMID:
26711572
15.

Identification of novel targets for the diagnosis and treatment of liver fibrosis.

Fagone P, Mangano K, Mammana S, Pesce A, Pesce A, Caltabiano R, Giorlandino A, Portale TR, Cavalli E, Lombardo GA, Coco M, Puleo S, Nicoletti F.

Int J Mol Med. 2015 Sep;36(3):747-52. doi: 10.3892/ijmm.2015.2264. Epub 2015 Jun 29.

PMID:
26135677
16.

Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir.

Fagone P, Mangano K, Quattrocchi C, Cavalli E, Mammana S, Lombardo GA, Pennisi V, Zocca MB, He M, Al-Abed Y, Nicoletti F.

Basic Clin Pharmacol Toxicol. 2015 Nov;117(5):306-15. doi: 10.1111/bcpt.12414. Epub 2015 May 25.

17.

Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats.

Fagone P, Mangano K, Mammana S, Cavalli E, Di Marco R, Barcellona ML, Salvatorelli L, Magro G, Nicoletti F.

Clin Immunol. 2015 Apr;157(2):198-204. doi: 10.1016/j.clim.2015.02.002. Epub 2015 Feb 19.

PMID:
25701800
18.

Saquinavir-NO inhibits IL-6 production in macrophages.

Momčilović M, Mangano K, Jevtić B, Mammana S, Stošić-Grujičić S, Nicoletti F, Miljković D.

Basic Clin Pharmacol Toxicol. 2014 Dec;115(6):499-506. doi: 10.1111/bcpt.12268. Epub 2014 Jun 18.

19.

Hypomethylating agent 5-aza-2'-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models.

Mangano K, Fagone P, Bendtzen K, Meroni PL, Quattrocchi C, Mammana S, Di Rosa M, Malaguarnera L, Coco M, Magro G, Di Marco R, Nicoletti F.

J Cell Physiol. 2014 Dec;229(12):1918-25. doi: 10.1002/jcp.24641.

PMID:
24700487
20.

Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis.

Saksida T, Miljkovic D, Timotijevic G, Stojanovic I, Mijatovic S, Fagone P, Mangano K, Mammana S, Farina C, Ascione E, Maiello V, Nicoletti F, Stosic-Grujicic S.

J Neuroimmunol. 2013 Sep 15;262(1-2):72-8. doi: 10.1016/j.jneuroim.2013.07.001. Epub 2013 Jul 24.

PMID:
23890777

Supplemental Content

Loading ...
Support Center